Steris Plc Quick Ratio (STE31) starting from the second quarter 2026 to second quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Steris Plc  (NYSE: STE31)

Steris Plc's Quick Ratio

STE31's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Steris Plc's Cash & cash equivalent grew by 10.12 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Steris Plc's Quick Ratio to 0.44, Quick Ratio remained below Steris Plc average.

Within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Steris Plc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from to 4028.

Explain Quick Ratio?
How much Cash & cash equivalents STE31´s has?
What are STE31´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/STE31/financial-strength
https://api.csimarket.com/api/v1/companies/STE31/fundamentals
https://api.csimarket.com/api/v1/companies/STE31/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
STE31 Quick Ratio (Sep 30 2026)
Q2
(Jun 30 2026)
Q1
(Dec 31 2022)
Q3
(Sep 30 2022)
Q2
(Jun 30 2022)
Q1
Y / Y Current Liabilities Change 38.39 %
Y / Y Cash & cash equivalent Change 67.9 %
Quick Ratio MRQ 0.44
STE31's Total Ranking # 4028
Seq. Current Liabilities Change -5.88 %
Seq. Cash & cash equivalent Change 10.12 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 206
Healthcare Sector # 1080
Overall Market # 4028


Quick Ratio Statistics
High Average Low
1.8 0.72 0.31
(Mar 31 2020)   (Sep 30 2022)




Financial Statements
Steris Plc's Current Liabilities $ 1,208 Millions Visit STE31's Balance sheet
Steris Plc's Cash & cash equivalent $ 531 Millions Visit STE31's Balance sheet
Source of STE31's Sales Visit STE31's Sales by Geography


Cumulative Steris Plc's Quick Ratio

STE31's Quick Ratio for the trailling 12 Months

STE31 Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 63.14 %
Y / Y Cash & cash equivalent TTM Growth 38.17 %
Quick Ratio TTM 0.3
Total Ranking TTM # 4048
Seq. Current Liabilities TTM Growth 8.63 %
Seq. Cash & cash equivalent TTM Growth 20.32 %


On the trailing twelve months basis STE31 Cash & cash equivalent soared by 67.9 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Steris Plc's Quick Ratio to 0.3, Quick Ratio remained below STE31 average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 264 other companies have achieved higher Quick Ratio than Steris Plc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from to 5116.

Explain Quick Ratio?
How much Cash & cash equivalents STE31´s has?
What are STE31´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 265
Healthcare Sector # 1252
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
0.63 0.45 0.16
(Dec 31 2020)   (Dec 31 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Sanara Medtech Inc   1.09 $ 17.788  Millions$ 16.282  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Koru Medical Systems Inc   1.08 $ 7.364  Millions$ 6.792  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions
Myomo Inc   0.93 $ 11.946  Millions$ 12.902  Millions
Strata Critical Medical Inc   0.92 $ 41.641  Millions$ 45.118  Millions
Haemonetics Corporation  0.87 $ 260.712  Millions$ 300.838  Millions
Treace Medical Concepts Inc   0.86 $ 39.798  Millions$ 46.079  Millions
Innovage Holding Corp   0.85 $ 162.993  Millions$ 192.479  Millions
Lifestance Health Group Inc   0.84 $ 218.818  Millions$ 261.129  Millions
Lucid Diagnostics Inc   0.83 $ 17.993  Millions$ 21.646  Millions
Seastar Medical Holding Corp  0.82 $ 3.989  Millions$ 4.841  Millions
Neuronetics Inc   0.82 $ 22.106  Millions$ 26.856  Millions
Orthopediatrics Corp  0.80 $ 44.229  Millions$ 55.632  Millions
Qhslab Inc   0.77 $ 0.190  Millions$ 0.247  Millions
Livanova Plc  0.76 $ 563.467  Millions$ 740.193  Millions
West Pharmaceutical Services Inc   0.72 $ 464.100  Millions$ 644.300  Millions
Resmed Inc   0.72 $ 1,010.742  Millions$ 1,406.488  Millions
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.69 $ 8.124  Millions$ 11.778  Millions
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions
Lensar Inc   0.64 $ 12.622  Millions$ 19.811  Millions
Orthofix Medical Inc   0.62 $ 86.322  Millions$ 138.385  Millions

Date modified: 2026-11-06T13:03:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.